Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
CN 119857078
PARP inhibitor child preparation and preparation process thereof
granted -
US 12280037
Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
granted -
US 12281305
Compounds and methods for reducing prion expression
granted -
US 12281083
2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof
granted -
US 12280159
Therapeutic protein-based nanoparticles for treating cancer
granted -
US 12280113
Ras inhibitors
granted -
US 12281329
Compositions and methods for immune cell modulation in adoptive immunotherapies
granted -
US 12280122
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
granted -
US 12281327
Lymphohematopoietic engineering using CAS9 base editors
granted -
US 12281321
Frataxin expression constructs having engineered promoters and methods of use thereof
granted -
US 12281310
Use of trinucleotide repeat RNAs to treat cancer
granted -
US 12281173
Methods for treating patients with hyperlipidemia by administering a PCSK9 inhibitor in combination with an ANGPTL3 inhibitor
granted -
US 12281164
Genetically engineered dual-targeting chimeric antigen receptor and use thereof
granted -
US 12281140
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted -
US 12281105
Contraceptive compounds and methods
granted -
US 12280124
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof
granted -
US 12281122
PI3K inhibitors
granted -
US 12281111
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
granted -
US 12281056
Methods for making and using endoxifen
granted -
US 12280029
Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators
granted -
US 12280055
Combination therapies
granted -
US 12280089
Dry powder formulation of caveolin-1 peptides and methods of use thereof
granted -
US 12280063
Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease
granted -
US 12281079
Quinoline derivatives, processes for their preparation and uses thereof for the treatment of cancer
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.